Biliary Tract Cancer near Rego Park, NY
We found 2,456 results within 10 miles for "Biliary Tract Cancer near Rego Park, NY"
- Listened/answered questions (76)
- Found trustworthy (75)
- Appt. wasn't rushed (73)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: As far back as I remember, I have been interested in improving the care of patients with cancer through research aimed at developing new and more effective therapies, and by providing compassionate care. I am fortunate to work at an institution that enables me to care for patients within an outstanding hospital and medical college, where I am surrounded by like-minded physicians and staff that are most concerned about the well-being of our patients and their family members. The close relationships I develop with my patients and the continued efforts by my colleagues and me to find a cure inspire me to come to work every day with new hope and determination.

- Appt. wasn't rushed (8)
- Explains conditions well (8)
- Listened/answered questions (7)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Vered Stearns completed the equivalent of a B.S. degree at the Tel Aviv University, Sackler Faculty of Medicine in 1989. After relocating to the United States, Dr. Stearns transferred to and graduated from the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School with a medical degree (M.D.) in 1992. She completed a residency in Internal Medicine and a fellowship in Medical Oncology at the Georgetown University where she developed an interest in translational breast cancer research and spent two additional years as a research fellow. Dr. Stearns was a faculty member at the Lombardi Comprehensive Cancer Center and the Georgetown University, and at the University of Michigan Comprehensive Cancer Center in Ann Arbor, Michigan before joining the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in 2002. She remained at Johns Hopkins and served in a variety of roles, including co-Director of the Breast Cancer Program, co-Director of the Breast and Ovarian Cancer Program, Director, Women's Malignancies Disease Group and inaugural Medical Director of the Under Armour Breast Health Innovation Center, until being recruited to Weill Cornell Medicine and New York-Presbyterian Hospital in 2023. At Weill Cornell Medicine, Dr. Stearns is Director of Translational Breast Cancer Research at the Department of Medicine, and Associate Director for Clinical Services at the Meyer Cancer Center. Her role in the Meyer Cancer Center will allow her to develop programs and to mentor team members across diseases throughout Manhattan, Brooklyn and Queens.Dr. Stearns's long-term research goal is to improve current therapies by individualizing strategies for the treatment and prevention of breast cancer. The main focus of Dr. Stearns's research includes the utilization of biomarkers to predict response to standard regimens used to treat and prevent breast cancer, and to introduce new interventions. Dr. Stearns and colleagues from the Consortium On Breast Cancer Pharamcogenomics (COBRA) Group were the first to evaluate the role of genetic variants in candidate genes such as CYP2D6 in tamoxifen metabolism, safety, and efficacy. This work has been extended to evaluate the role of genetic variants in aromatase inhibitor associated outcomes. She has also conducted clinical investigations of epigenetic modifying agents across the breast cancer continuum. She is evaluating whether histone deacetylase inhibitors enhance response to immunotherapy. Having demonstrated that methylation markers predict breast cancer risk, she is evaluating whether natural compounds can reverse these modifications.Dr. Stearns has received numerous grants and awards to fund her innovative research. She was a recipient of early career awards including a Clinical Research Training Grant from the American Cancer Society, and was one of the first five recipients of the prestigious Damon Runyon Clinical Investigator Award. Subsequently she was the inaugural recipient of the American Society of Clinical Oncology (ASCO) Advanced Clinical Research Award.She served as a Board Member of the National Accreditation Program for Breast Centers (NAPBC) for the American College of Surgeons (ACS), and was elected in 2020 as Fellow of the American Society of Clinical Oncology (FASCO). Her work has already had a positive impact on the lives of many women, and in 2017, Dr. Stearns was selected by Forbes as one of 27 top breast cancer oncologists in the United States. Dr. Stearns is Vice Chair of the NRG Translational Science Committee, and Co-Chair of the NRG Breast?Translational?Working Group. In these roles, she works closely with Group members as they investigate correlative biomarkers obtained through breast cancer trials.

- Listened/answered questions (68)
- Explains conditions well (68)
- Found trustworthy (64)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: My practice focuses on treating gastrointestinal malignancies, including colorectal, pancreatic, stomach, biliary, neuroendocrine, and liver cancers. I place great value on having strong physician-patient relationships and feel this is especially important in cancer care. I not only provide state-of-the art cancer treatment for my patients and their families, but comprehensive support through a compassionate and multidisciplinary approach. Through clinical research, I am able to offer my patients access to the latest therapies such as radiolabeled monoclonal antibodies, cancer "vaccines," immunotherapy, and other novel targeted agents. At Weill Cornell Medicine and New York-Presbyterian Hospital, we utilize a bench to bedside approach and are committed to bringing the most promising new treatments out of the lab and directly to patients often years before they are widely available elsewhere

- Listened/answered questions (63)
- Found trustworthy (63)
- Appt. wasn't rushed (62)
- View 1 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (4)
- Listened/answered questions (4)
- Explains conditions well (4)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Parissa Tabrizian, MD is a General Surgery Specialist who practices in New York, NY. She is 45 years old and has been practicing for 23 years. Dr. Parissa Tabrizian, MD is affiliated with Mount Sinai Hospital.

- Appt. wasn't rushed (20)
- Listened/answered questions (20)
- Explains conditions well (20)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: Giving a listening ear to my patients is my most precious source of clinical information.

- Found trustworthy (13)
- Appt. wasn't rushed (4)
- Listened/answered questions (4)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: At Moffitt Cancer Center, we are working tirelessly in the areas of patient care, research and education to advance one step further in fighting cancer. As a National Cancer Institute-designated Comprehensive Cancer Center, we are committed to the health and safety of our patients and dedicated to providing expert cancer care. From enhanced quality of life to complete remission, Moffitt is Florida's top choice aiming to achieve the best outcome for each patient.

- Explains conditions well (41)
- Appt. wasn't rushed (39)
- Listened/answered questions (39)
- View 2 more provider attributes
- Offers Telehealth

- Listened/answered questions (75)
- Appt. wasn't rushed (70)
- Found trustworthy (70)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: Dr. Shah and the Gastrointestinal Oncology group are committed to providing excellent and personalized care for you and your loved ones. We would welcome the opportunity to take part in your care, whether it involves primary management or for consultation in conjunction with your treating physicians. Ensuring you are receiving the best and most comprehensive treatment for your malignancy is our aim. Please feel free to contact us for an appointment, or have your physician contact us to discuss your care.

- Offers Telehealth
Biography: Dr. Myron Schwartz, MD is a General Surgery Specialist who practices in New York, NY. He is 72 years old and has been practicing for 49 years. Dr. Myron Schwartz, MD is affiliated with Mount Sinai Hospital.

- Listened/answered questions (29)
- Explains conditions well (29)
- Appt. wasn't rushed (28)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (22)
- Listened/answered questions (22)
- Explains conditions well (22)
- View 1 more provider attributes

- Appt. wasn't rushed (30)
- Listened/answered questions (30)
- Explains conditions well (30)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: Pancreatic cancer has been my area of clinical and research focus for the past 15 years. I participated in the process of recognition that outcomes of complex surgery such as that for pancreatic cancer are better in high volume centers when performed by experienced surgeons. In 2006, I conceived, funded and built a multidisciplinary unit with the mission of improving overall outcomes in pancreatic cancer care by integrating the care of multiple medical specialists.

- Appt. wasn't rushed (1)
- Listened/answered questions (1)
- Explains conditions well (1)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Bobby Liaw, MD is a Hematology Specialist who practices in New York, NY. He is 42 years old and has been practicing for 16 years. Dr. Bobby Liaw, MD is affiliated with Mount Sinai Queens, Mount Sinai Hospital and Mount Sinai Brooklyn.

- Appt. wasn't rushed (15)
- Listened/answered questions (15)
- Explains conditions well (15)
- View 2 more provider attributes
- Offers Telehealth
Biography: Dr. Daniel Labow, MD is a General Surgery Specialist who practices in New York, NY. He is 57 years old. Dr. Daniel Labow, MD is affiliated with Mount Sinai Brooklyn, Mount Sinai Morningside and Mount Sinai Queens.

- Listened/answered questions (34)
- Explains conditions well (34)
- Appt. wasn't rushed (33)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (10)
- Listened/answered questions (10)
- Explains conditions well (10)
- View 2 more provider attributes
- Offers Telehealth
Biography: Paul Chapman, MD is currently the Chief Medical Research Officer for the Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian Hospital. Dr. Chapman received his M.D. degree from Weill Cornell Medical College in 1981 and trained in internal medicine as an intern and resident at the University of Chicago Hospitals and Clinics from 1981-1984. After that, he returned to New York as a medical oncology Fellow at Memorial Sloan Kettering Cancer where he focused on immunotherapy of melanoma in the laboratory of Dr. Alan Houghton. He joined the faculty of Memorial Sloan Kettering Cancer Center (MSKCC) in 1988 and worked there through 2023 as a tenured Attending Physician. During this time at MSKCC, Dr. Chapman led many clinical and laboratory studies designed to develop new and improved treatments for melanoma. This included the first BRAF targeted therapy trial and several immunotherapy trials. His research continues to focus on developing new treatments for melanoma.

- Appt. wasn't rushed (10)
- Listened/answered questions (10)
- Explains conditions well (10)
- View 2 more provider attributes

- Appt. wasn't rushed (7)
- Listened/answered questions (7)
- Felt Respected (1)
- Offers Telehealth
Biography: Dr. Celina Ang, MD is a Hematology Specialist who practices in New York, NY. She is 46 years old. Dr. Celina Ang, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

- Appt. wasn't rushed (8)
- Listened/answered questions (8)
- Explains conditions well (8)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Peter Kozuch, MD is a Hematology Specialist who practices in New York, NY. He is 57 years old and has been practicing for 31 years. Dr. Peter Kozuch, MD is affiliated with Mount Sinai Hospital, Mount Sinai Morningside and Mount Sinai Queens.

- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- Explains conditions well (2)
- View 1 more provider attributes
- Offers Telehealth

- Listened/answered questions (17)
- Explains conditions well (17)
- Found trustworthy (17)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: I have always been exquisitely sensitive to the cultural and emotional aspects of being ill. Fortunately, due to innovative treatments as well as a change in the medical mindset, we are now able to approach cancer therapy with a goal of maximizing quality of life while at the same time controlling disease. In many areas of oncology, especially in advanced, difficult to treat cancers and metastatic disease, the key to pursuing therapy is individualizing treatment to the patient's personal ability to withstand therapy. Thinking of cancer as a chronic disease and gearing therapies to be sustainable and effective is among one of my most important goals as I move forward with our clinical research and cancer treatment programs.

- Explains conditions well (14)
- Appt. wasn't rushed (13)
- Listened/answered questions (13)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (4)
- Listened/answered questions (4)
- Explains conditions well (4)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.
